TransMedics Group Inc

TransMedics Group Inc (TMDX) SEC filings

TransMedics Group Inc (TMDX) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported TMDX revenue for 2025-09-30 was $143.8M. Net income was $84.9M. Revenue was down 8.6% from 2025-06-30 to 2025-09-30. TMDX currently screens at market cap $2.53B and trailing P/E 16.8. The TMDX filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what TransMedics Group Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

0

10-K

0

10-Q

1

8-K

0

Form 4

Recent filings

8-K1.018.019.01

8-K exhibit

EDGAR

EDGAR is the official archive. Browse all TMDX filings.

Frequently asked questions

What did TMDX just say?

TMDX cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.

Where are TMDX SEC filings?

1 cached filing is on this page. EDGAR remains the official archive (CIK 0001756262).

What is an 8-K Item 2.02?

Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.